2026年
- NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.
Ikehara T, Otsu H, Tobo T, Hosoda K, Abe T, Hashimoto M, Nakano Y, Dairaku K, Ono Y, Miyata Y, Matsumoto C, Tatsumi T, Higuchi S, Ofuchi T, Tsujimoto A, Ando Y, Hu Q, Yonemura Y, Shimizu A, Masuda T, Soejima Y, Mimori K.
Cancer Sci. 2026 Jun 30:10.1111/cas.70456. doi: 10.1111/cas.70456. Online ahead of print.PMID: 42374986
- Epidermoid Cysts in an Intrapancreatic Accessory Spleen Mimicking Pancreatic Neoplasms: Two Case Reports and a Literature Review of Japanese Cases.
Li X, Hu Q, Takashi Y, Kawata K, Shibuta S, Ando Y, Otsu H, Yonemura Y, Tobo T, Mimori K.
Surg Case Rep. 2026;12(1):26-0039. doi: 10.70352/scrj.cr.26-0039. Epub 2026 May 26.PMID: 42220556
- Clinical practice guidelines for telesurgery, 2nd Edition : Committee for the Promotion of Remote Surgery Implementation, Japan Surgical Society.
Mori M, Hirano S, Hakamada K, Oki E, Ito T, Urushidani S, Uyama I, Eto M, Ebihara Y, Kanemitsu Y, Kawashima K, Kanno T, Kitsuregawa M, Kinugasa Y, Kitatsuji H, Sato T, Sato F, Shimokawa T, Shimamoto H, Takiguchi S, Takemasa I, Tokunaga M, Nakauchi M, Noshiro H, Masaki Mandai, Koshi Mimori, Morohashi H, Yoshizumi T, Watanabe G, Sakai Y, Ikeda N, Taketomi A.
Surg Today. 2026 Jul;56(7):1047-1065. doi: 10.1007/s00595-026-03295-z. Epub 2026 May 29.PMID: 42213119
- [Elucidation of Natural Killer (NK) Cell Evasion Mechanisms in Colorectal Carcinogenesis Using Single-Cell RNA Sequencing and Spatial Gene Expression Analysis].
Mimori K.
Gan To Kagaku Ryoho. 2026 Apr;53(4):244-248.PMID: 42178626
- Visionary Leadership in Cancer Care: An Interview With Professor Timothy J. Eberlein.
Shirabe K, Mimori K, Mori M, Kitagawa Y.
Ann Gastroenterol Surg. 2026 Mar 7;10(3):638-642. doi: 10.1002/ags3.70211. eCollection 2026 May.PMID: 42146824
- GDF15 promotes 5-Fluorouracil and Oxaliplatin resistance by promoting stem cell-like phenotype in colorectal cancer.
Hashimoto M, Urabe S, Hata T, Chinen Y, Haruna K, Takeda M, Sekido Y, Hamabe A, Ogino T, Miyoshi N, Tobo T, Mimori K, Uemura M, Eguchi H, Doki Y.
Br J Cancer. 2026 Aug;135(4):659-673. doi: 10.1038/s41416-026-03379-0. Epub 2026 May 12.PMID: 42120524
- MiR-155-driven loss of ICOSL and SOCS1 in EBV+ gastric cancers renders abundant cytotoxic T cells ineffective, enabling immune evasion.
Nuovo GJ, Mimori K, Otsu H, Tili E, Croce CM.
Proc Natl Acad Sci U S A. 2026 May 12;123(19):e2536375123. doi: 10.1073/pnas.2536375123. Epub 2026 May 8.PMID: 42102000
- TONSL Promotes Hepatocellular Carcinoma Progression by Inhibiting Apoptosis Through Homologous Recombination Repair.
Tsujimoto A, Otsu H, Ofuchi T, Ikehara T, Hirose K, Shibuta S, Omachi K, Takahashi Y, Ono Y, Higuchi S, Tatsumi T, Hosoda K, Hu Q, Yonemura Y, Masuda T, Sho M, Mimori K.
Cancer Sci. 2026 Jul;117(7):1852-1866. doi: 10.1111/cas.70386. Epub 2026 Apr 27.PMID: 42037569
- Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinoma.
Ikehara T, Otsu H, Tobo T, Hosoda K, Hirose K, Ofuchi T, Tsujimoto A, Shibuta S, Kawata K, Itoyama S, Omachi K, Takahashi Y, Motomura Y, Hiraki Y, Ando Y, Hu Q, Yonemura Y, Shimizu A, Masuda T, Soejima Y, Mimori K.
J Gastroenterol. 2026 Jun;61(6):765-782. doi: 10.1007/s00535-026-02380-x. Epub 2026 Apr 20.PMID: 42007975
- Proteasome inhibitor, ixazomib prevents topoisomerase-I degradation and reverses irinotecan resistance in colorectal cancer.
Ebata Y, Ando K, Hasuda H, Mimori K, Unan EC, Pulukuri S, Tiku A, Berger A, Oki E, Bharti A, Yoshizumi T.
Mol Oncol. 2026 Apr 15:10.1002/1878-0261.70256. doi: 10.1002/1878-0261.70256. Online ahead of print.PMID: 41987550
- Intratumoral Fusobacterium nucleatum Drives Cancer-Associated Fibroblasts Enrichment and Immune Exclusion in Esophageal Squamous Cell Carcinoma.
Ofuchi T, Hu Q, Omachi K, Kanemitsu K, Otsu H, Yonemura Y, Tobo T, Baba Y, Iwatsuki M, Mimori K.
Ann Gastroenterol Surg. 2025 Nov 13;10(2):611-620. doi: 10.1002/ags3.70116. eCollection 2026 Mar.PMID: 41799583
- Multicenter ex vivo evaluation of an α-mannosidase-targeted fluorescent probe for intraoperative margin assessment in breast cancer.
Ueo H, Ueo H, Doi T, Yamaguchi M, Akashi-Tanaka S, Takamaru T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Gamachi A, Kai Y, Kubota Y, Kunii S, Nagamori Y, Fujita K, Urano Y, Ando Y, Mimori K, Masuda T.
Sci Rep. 2026 Mar 3;16(1):11789. doi: 10.1038/s41598-026-42316-2.PMID: 41776279
- Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma.
Hosoda K, Masuda T, Saito H, Koike K, Ando Y, Abe T, Hashimoto M, Nakano Y, Dairaku K, Hirose K, Matsumoto C, Ikehara T, Ofuchi T, Kawata K, Omachi K, Tobo T, Tsuda Y, Otsu H, Yonemura Y, Shimizu A, Soejima Y, Mimori K.
Hepatol Res. 2026 May;56(5):806-819. doi: 10.1111/hepr.70135. Epub 2026 Feb 14.PMID: 41689774
- Aberrant Hippo-YAP/TEAD Signaling Drives Malignant Transcriptional Reprogramming in External Auditory Canal Squamous Cell Carcinoma.
Sato K, Komune N, Ono M, Itoyama S, Hongo T, Nakano T, Koike K, Taguchi K, Mimori K, Gutkind JS, Masuda M, Nakagawa T.
Cancer Res Commun. 2026 Feb 1;6(2):260-272. doi: 10.1158/2767-9764.CRC-25-0626.PMID: 41524724
- PSMD12 Overexpression Promotes Lung Adenocarcinoma Progression via Ubiquitin-Proteasome Pathway Dysregulation.
Ono Y, Otsu H, Masuda T, Kosai K, Shibuta S, Hirose K, Ofuchi T, Ando Y, Kawata K, Tsuda Y, Yonemura Y, Tobo T, Takenaka T, Yoshizumi T, Mimori K.
Cancer Sci. 2026 Jan 6. doi: 10.1111/cas.70290. Online ahead of print.PMID: 41496578
- ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation.
Abe T, Masuda T, Tobo T, Hashimoto M, Nakano Y, Saito H, Ofuchi T, Ikehara T, Tsujimoto A, Nakano T, Dairaku K, Takahashi J, Koike K, Kawata K, Ando Y, Hosoda K, Tatsumi T, Hirose K, Higuchi S, Otsu H, Yonemura Y, Eto K, Ikegami T, Mimori K.
Cancer Sci. 2026 Jan;117(1):90-104. doi: 10.1111/cas.70224.PMID: 41125417